← Back to headlines
Biogen and Denali Discontinue Parkinson's Therapy After Trial Setback
Biogen and Denali Therapeutics have announced they will discontinue their Parkinson's disease therapy after it failed to meet expectations in a mid-stage clinical trial.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Scientists Debunk Common Beliefs About Strawberries
24m ago
Key Evidence of Water Disappears on Jupiter's Moon Europa
26m ago
Scientists Predict Earth Day Will Last 25 Hours in 200 Million Years
31m ago